Fundies.
English

Fresenius Kabi Pharmaceuticals Holding, Inc.

EDGAR
Annual report (10-K) · filed 2011-02-23

12 filing records in this dataset, filed from 2008-11-14 to 2011-02-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

331 million USD

2010-09-30 · USD

Exact inputs and evidence

Operating margin

40.11%

2010-09-30 · %

Exact inputs and evidence
  • Operating Income: 132908000 USD Source
  • Revenue: 331321000 USD Source

Operating cash flow

12.4 million USD

2010-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 73559000 USD Source
  • Operating Cash Flow: 61148000 USD Source

Free cash flow

9.79 million USD

2010-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 73559000 USD Source
  • Operating Cash Flow: 61148000 USD Source
  • Capital Expenditure: 7470000 USD Source
  • Capital Expenditure: 4847000 USD Source
Cash and cash equivalents
6.73 million USD Source
Exact value

6726000 USD

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.11 billion USD

2009-10-01 – 2010-09-30

Exact inputs and evidence
  • Revenue: 888686000 USD · 2009-01-01 – 2009-12-31 Source
  • Revenue: 632186000 USD · 2009-01-01 – 2009-09-30 Source
  • Revenue: 216199000 USD · 2010-01-01 – 2010-03-31 Source
  • Revenue: 305228000 USD · 2010-04-01 – 2010-06-30 Source
  • Revenue: 331321000 USD · 2010-07-01 – 2010-09-30 Source

Net income

129 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence
  • Net income: -30385000 USD · 2009-01-01 – 2009-12-31 Source
  • Net income: -76023000 USD · 2009-01-01 – 2009-09-30 Source
  • Net income: 11866000 USD · 2010-01-01 – 2010-03-31 Source
  • Net income: 19219000 USD · 2010-04-01 – 2010-06-30 Source
  • Net income: 52128000 USD · 2010-07-01 – 2010-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-02-23.

Financial data available through: 2009-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2009-12-31
  • Operating income: 2 of 11 periods available· newest 2009-12-31
  • Net income: 2 of 11 periods available· newest 2009-12-31
  • operating cash flow: No compatible figures in this window
  • capital expenditure: No compatible figures in this window
  • Total assets: 2 of 11 periods available· newest 2009-12-31
  • Total liabilities: 2 of 11 periods available· newest 2009-12-31
  • Current assets: 2 of 11 periods available· newest 2009-12-31
  • Current liabilities: 2 of 11 periods available· newest 2009-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2009-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +216.4%

    Prior period

    USD 280.84 million

    –

    Current period

    USD 888.69 million

    –

    Exact inputs and evidence

    888686000 − 280836000 = 607850000 USD

    280836000 USD · 2008-01-01 – 2008-12-31

    Inspect prior input Prior source

    888686000 USD · 2009-01-01 – 2009-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 282.06 million

    Prior period

    −USD 312.45 million

    –

    Current period

    −USD 30.39 million

    –

    Exact inputs and evidence

    -30385000 − -312445000 = 282060000 USD

    -312445000 USD · 2008-01-01 – 2008-12-31

    Inspect prior input Prior source

    -30385000 USD · 2009-01-01 – 2009-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

  • Revenue USD 888.69 million 100% of revenue
  • Cost of revenue USD 0 0% of revenue
  • Operating expenses USD 162.37 million 18% of revenue
  • Other operating costs Derived USD 453.56 million 51% of revenue
  • Operating income USD 272.76 million 31% of revenue
  • Tax, interest and other Derived USD 303.15 million 34% of revenue
  • Net income −USD 30.39 million −3.4% of revenue

Cash

  • Operating cash flow Unavailable An input is unavailable.
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2008 Operating loss: operating costs were 214% of revenue.
  • 2009 Net loss: net income was −3.4% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2008 2008-01-01 – 2008-12-31280836000 600380000 Derived -319544000 -7099000 Derived -312445000 Unavailable
Source
2009 2009-01-01 – 2009-12-31888686000 615922000 Derived 272764000 303149000 Derived -30385000 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 888.7M 2009
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.959.8M719.8M479.9M239.9M0.020082009
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Revenue280836000
2009Revenue888686000

Revenue growth

Change in revenue from the same financial period one year earlier.

216.4% 2009
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.234%175%117%58%0%20082009
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2008Year over yearNo prior comparable period
2009Year over year216.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 30.7% 2009
Net margin -3.4% 2009
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.42%0%-42%-83%-125%20082009
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2008Operating margin-113.8%
2009Operating margin30.7%
2008Net margin-111.3%
2009Net margin-3.4%
2008Free cash flow marginNot reported
2009Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Operating cash flowNot reportedNo source recorded
2009Operating cash flowNot reportedNo source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2008Free cash flowUnavailableNo source recorded
2009Free cash flowUnavailableNo source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

88.9% 2009
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.96%72%48%24%0%20082009
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2008Liabilities / assets88.6%
2009Liabilities / assets88.9%

Current assets to current liabilities

Current assets divided by current liabilities.

0.6× 2009
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.47×1.10×0.73×0.37×0.00×20082009
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2008Current assets / current liabilities1.36×
2009Current assets / current liabilities0.6×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2008 2008-01-01 – 2008-12-31
−USD 312.45 million
Exact value

Exact value: -312445000 USD

2008-01-01 – 2008-12-31: -312445000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2009 2009-01-01 – 2009-12-31
−USD 30.39 million
Exact value

Exact value: -30385000 USD

2009-01-01 – 2009-12-31: -30385000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001439449, 1439449, edgar:1439449

Also known as Fresenius Kabi Pharmaceuticals Holding, LLC